Biesterfeld Spezialchemie and Jubilant Life Sciences celebrate the 20th anniversary of their partnership this year. Biesterfeld Spezialchemie distributes Jubilant Life Science’s select range of products to a mutually agreed set of customers in Europe. This successful partnership – spanning the last two decades – is a shining example of the collaborative work and commitment shared between the two companies.
“The two decades of successful alliance between Jubilant Life Sciences and Biesterfeld is an important milestone and depicts strong commitment towards shared values. This global partnership combines the manufacturing strength and product innovation of Jubilant with Biesterfeld’s excellent market knowledge and customer loyalty to our selected product range to chosen customers in Europe”, said Rajesh Srivastava, CEO, Life Science Ingredients business, Jubilant Life Sciences.
“Jubilant is recognised as a quality-conscious brand with a diverse product range of high-quality intermediates for pharmaceutical and other industrial applications. We sell our products to customers directly as well as through chosen distributors with customer protection agreements, across the globe. The partnership has helped Jubilant leverage on Biesterfeld’s reputation as one of the important European distribution partners and achieve mutual success,” added Mr. Srivastava.
The Jubilant portfolio offered by Biesterfeld includes Pyridine and Picolines as well as some selected derivatives, which are used as intermediates, catalysts or solvents in chemical synthesis. “Our portfolio covers a broad spectrum of applications and market segments, such as pharmaceuticals, flavour & fragrance, agro and personal care, but also customer-specific product developments. Thanks to existing registrations, the entire product range complies with the European requirements of the REACH regulation,” said Dr. Fritjof Weidner, Market Manager, Biesterfeld Spezialchemie.
“Due to necessary environmental regulations for producers, the availability of products from Asia is sometimes uncertain. Raw material prices are rising and the supply of some chemicals is limited. We are pleased to have Jubilant at our side as a partner who has recognised these challenges at an early stage and can meet the requirements for this market, including the aspects of environmental and health and safety compliance,” said Elmar Braasch, Senior Sales Manager, Biesterfeld Spezialchemie.
About Jubilant Life Sciences Limited
Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions. The Pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile and Non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada and a network of over 50 radio-pharmacies in the US. The Life Science Ingredients segment, is engaged in Specialty Intermediates, Nutritional Products and Life Science Chemicals through 5 manufacturing facilities in India. The Drug Discovery Solutions segment, provides proprietary in-house innovation & collaborative research and partnership for out-licensing through 3 world class research centres in India and USA. Jubilant Life Sciences Limited has a team of around 7,600 multicultural people across the globe and is committed to deliver value to its customers across over 100 countries. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies globally. For more info: www.jubl.com.
20095 Hamburg, Germany
Phone: +49 40 32008-326